NYSE: PHGE - BiomX Inc.

Altı ay boyunca karlılık: -78.82%
Sektör: Healthcare

Promosyon programı BiomX Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında

BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials.

daha fazla ayrıntı
The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

EBITDA -0.0224
EV/EBITDA 0.7273
IPO date 2019-03-13
ISIN US09090D1037
Industry Biotechnology
P/BV 0.6483
P/S -41.66
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка -0.000134
Сайт https://www.biomx.com
Цена ао 0.3357
Число акций ао 0.05133 млрд
Günlük fiyat değişimi: +16.67% (0.6389)
Haftalık fiyat değişimi: +20.23% (0.62)
Aylık fiyat değişimi: +23.99% (0.6012)
3 ayda fiyat değişimi: -29.35% (1.055)
Altı ayda fiyat değişimi: -78.82% (3.52)
Yıllık fiyat değişimi: +166.21% (0.28)
3 yılda fiyat değişimi: -49.29% (1.47)
5 yılda fiyat değişimi: -90.91% (8.2)
10 yılda fiyat değişimi: 0% (0.7454)
Yılbaşından bu yana fiyat değişimi: +35.53% (0.55)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S -41.98 0
P/BV 4.86 3
P/E 0 0
EV/EBITDA -0.5302 0
Toplam: 2.88

Yeterlik

İsim Anlam Seviye
ROA, % -45 0
ROE, % -849.37 0
Toplam: 3.33

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.442 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 166.42 10
karlılık Ebitda, % 1.85 1
karlılık EPS, % 51.28 7
Toplam: 5
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Orbimed Advisors LLC. 4517589 8.18
Johnson & Johnson 2133402 3.86
8vc Gp I, LLC 1086191 1.97
Renaissance Technologies, LLC 110294 0.2
MMCAP International, Inc. SPC 96805 0.18
Bridgeway Capital Management, Inc. 49500 0.09
Citadel Advisors Llc 33582 0.06
Walleye Capital LLC 21056 0.04
XTX Topco Ltd 14531 0.03
Susquehanna International Group, LLP 10908 0.02



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Jonathan Eitan Solomon MBA CEO & Director 714.37k 1977 (48 yıllar)
Ms. Marina Wolfson CPA CFO & Secretary 337.51k 1984 (41 yıl)
Dr. Merav Bassan Ph.D. Chief Development Officer 437.71k 1966 (59 yıllar)
Prof. Rotem Sorek Ph.D. Scientific Founder N/A
Dr. Eran Elinav M.D., Ph.D. Scientific Founder N/A
Dr. Timothy K. Lu M.D., Ph.D. Scientific Founder N/A 1981 (44 yıl)
Ms. Inbal Benjamini-Elran C.H.R.O N/A
Mr. Assaf Oron Chief Business Officer 352.04k 1974 (51 yıl)

Adres: Israel, Ness Ziona, 22 Einstein Street - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.biomx.com